Hyperliquid Merger Vote Postponed Because of Insufficient Participation

Merger Vote Postponement: The Hyperliquid $1 billion merger vote between Sonnet BioTherapeutics and Rorschach I LLC has been postponed to December 2, 2025, due to low voter turnout, despite over 95% support for the merger.

Impact on HYPE Token: The delay is affecting financial projections and causing volatility in the HYPE token, which is fluctuating between $35 and $60, highlighting the market's anticipation for the merger's completion.

Institutional Engagement: The merger involves significant institutional interest, including Paradigm Operations LP and partnerships with Hyperion DeFi, indicating a strong backing that could influence the merger's success.

Historical Context: Past merger events, such as those involving BitDAO and Lido, suggest that similar situations can lead to price fluctuations, emphasizing the importance of governance participation in the financial community.